MicrobiologybioRxiv
A specific anti-IFITM2 antibody bars the way to SARS-CoV-2 entry into host cells.
A. Basile, C. Zannella, M. De Marco…·L. Marzullo
This study identifies an anti-IFITM2 antibody that blocks SARS-CoV-2 entry into host cells and reduces cytopathic effects and syncytia formation.
DOI 10.1016/j.antiviral.2023.105546